Hinokiflavone is a novel CK2 inhibitor promoting apoptosis and synergizing with chemotherapeutic agents in cisplatin resistant bladder cancer cells

Tsung‐Han Hsieh(Taipei Medical University Hospital), Chun‐Han Chen(Wan Fang Hospital)

Scientific Reports

July 1, 2025

10.1038/s41598-025-06543-3

Cited by 3

Related Papers

MPT0G612, a Novel HDAC6 Inhibitor, Induces Apoptosis and Suppresses IFN-γ-Induced Programmed Death-Ligand 1 in Human Colorectal Carcinoma Cells

|Cancers|2019|40

Trichlorobenzene-substituted azaaryl compounds as novel FGFR inhibitors exhibiting potent antitumor activity in bladder cancer cells <i>in vitro</i> and <i>in vivo</i>

|Oncotarget|2016|21

Targeting Autophagy by MPT0L145, a Highly Potent PIK3C3 Inhibitor, Provides Synergistic Interaction to Targeted or Chemotherapeutic Agents in Cancer Cells

|Cancers|2019|20

Cucurbitacin E Exerts Anti-Proliferative Activity via Promoting p62-Dependent Apoptosis in Human Non-Small-Cell Lung Cancer A549 Cells

|Current Issues in Molecular Biology|2023|10

Targeting PPARγ via SIAH1/2-mediated ubiquitin-proteasomal degradation as a new therapeutic approach in luminal-type bladder cancer

|Cell Death and Disease|2024|5